Advancing Sickle Cell Disease Management in Africa: Drawing Lessons from the UK’s NHS Investment in Automated Red Blood Cell Exchange Technology (Spectra Optia®)
Burden of disease Sickle cell disease (SCD) remains a significant public health challenge across Africa, with 75% of SCD cases occurring in Sub-Saharan Africa (SSA). Without proactive measures, it is estimated that 50-90% of affected children do not survive beyond their fifth birthday.[1] However, recent advancements in treatment, particularly red blood cell exchange technologies, offer […]
